2017
DOI: 10.1016/j.aimed.2017.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Anti-hyperglycemic effect of aqueous extract of Juglans regia L. leaf (walnut leaf) on type 2 diabetic patients: A randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 29 publications
0
12
1
Order By: Relevance
“…(2015) evaluated the anti-hyperuricemia potential of J. regia leaves by determining the xanthine oxidase inhibitory activity. Moreover, the extensive evidences on the anti-diabetic activity of walnut leaves encouraged Abdoli et al (2017) to carry out a human trial using walnut leaves-based preparations in Type II diabetic patients, obtaining positive results for the reduction of the glycemic index and HbA1c (glycated hemoglobin) values.…”
mentioning
confidence: 99%
“…(2015) evaluated the anti-hyperuricemia potential of J. regia leaves by determining the xanthine oxidase inhibitory activity. Moreover, the extensive evidences on the anti-diabetic activity of walnut leaves encouraged Abdoli et al (2017) to carry out a human trial using walnut leaves-based preparations in Type II diabetic patients, obtaining positive results for the reduction of the glycemic index and HbA1c (glycated hemoglobin) values.…”
mentioning
confidence: 99%
“…The review included 195 individuals from 4 studies. All 4 RCTs were conducted in Iran, on T2DM patients, and both genders [ 13 22 23 24 ]. Sample sizes varied from 37 to 61, the duration of intervention in the studies was 8 and 12 weeks, whilst the dosage of JRLE varied from 200 to 750 mg/day; where in one study, the intervention was defined as 100 mg/day for one week, then continued with 200 mg/day for 7 weeks [ 13 ].…”
Section: Resultsmentioning
confidence: 99%
“…However, current evidence from trial studies investigating the effectiveness of JRLE on blood glucose and lipid parameters of T2DM patients in humans is controversial [ 13 22 23 24 ]. Rabiei et al [ 13 ] didn’t observe any significant effects of 200 mg/d JRLE on blood glucose and homeostasis model assessment of insulin resistance (HOMA-IR) levels whilst Hosseini et al [ 23 ] reported that consumption of 100 mg JRLE 2 times a day improves glycemic control and lipid profile.…”
Section: Introductionmentioning
confidence: 99%
“…4 Currently, the State Pharmacopoeia of the Russian Federation there is no pharmacopoeial article on medicinal plant raw materials -bark of walnut. 5,6 Thus, the study of indicators of quality of medicinal plants bark of walnut is relevant.…”
Section: Introductionmentioning
confidence: 99%